Data as of .
BBH vs PBE: which is really different?
BBH and PBE hold 44% of their weight in the same names, and BBH returned more over the year.
ETFIQ Off-Index Score: BBH scores higher
How much of it is not the index it is sold as an alternative to?
A percentile among the 379 thematic ETFs with a holdings filing. It is a position in a set, not a rating, and neither end of it is a recommendation. All thematic ETFs ranked by it · How it is computed
44% of the two portfolios are the same securities at the same weight.
What they hold in common
By the books each fund has filed, BBH and PBE hold 44% of their money in the same securities at the same weight.
| Holding | BBH | PBE |
|---|---|---|
| Gilead Sciences Inc | 13.81% | 5.27% |
| Natera Inc | 4.97% | 5.70% |
| Regeneron Pharmaceuticals Inc | 7.00% | 4.89% |
| Vertex Pharmaceuticals Inc | 8.32% | 4.77% |
| Amgen Inc | 15.03% | 4.53% |
| Illumina Inc | 3.68% | 5.53% |
| Moderna Inc | 5.05% | 2.75% |
| Biogen Inc | 2.71% | 5.07% |
| Incyte Corp | 2.39% | 2.73% |
| United Therapeutics Corp | 2.12% | 2.70% |
| Neurocrine Biosciences Inc | 1.50% | 2.70% |
| Biomarin Pharmaceutical Inc | 1.25% | 2.74% |
| Only in BBH | Only in PBE |
|---|---|
| Argenx Se 4.93% | Royalty Pharma PLC 4.88% |
| Iqvia Holdings Inc 4.61% | Novavax Inc 3.03% |
| Revolution Medicines Inc 4.09% | Sarepta Therapeutics Inc 3.01% |
| Guardant Health Inc 3.15% | Exelixis Inc 2.91% |
| Beone Medicines Ltd 2.75% | Halozyme Therapeutics Inc 2.91% |
| Alnylam Pharmaceuticals Inc 2.73% | TG Therapeutics Inc 2.91% |
| Insmed Inc 2.31% | Repligen Corp 2.76% |
| Biontech Se 1.62% | Protagonist Therapeutics Inc 2.69% |
Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated Sep 18, 2026 and Sep 19, 2026.
Performance, window by window
| Window | Total return | vs the S&P 500 | vs the Nasdaq-100 | |||
|---|---|---|---|---|---|---|
| BBH | PBE | BBH | PBE | BBH | PBE | |
| 3 months | +24.8% | +13.2% | +22.5 pts | +11.0 pts | +27.3 pts | +15.7 pts |
| 6 months | +29.0% | +25.9% | +11.0 pts | +7.8 pts | +4.8 pts | +1.6 pts |
| 1 year | +40.5% | +36.2% | +23.9 pts | +19.6 pts | +18.7 pts | +14.4 pts |
| 3 years | +48.9% | +65.0% | −29.5 pts | −13.4 pts | −49.3 pts | −33.1 pts |
| Since launch | +732.7% | +492.4% | −70.8 pts | −311.1 pts | −957.5 pts | −1197.8 pts |
| BBH VanEck Biotech ETF Holds 24 stocks in biotech, 60% of its weight in S&P 500 companies | PBE Invesco Biotechnology & Genome ETF Holds 33 stocks in biotech, 30% of its weight in S&P 500 companies | |
|---|---|---|
| Issuer | VanEck | Invesco |
| Theme | Biotech | Biotech |
| In the S&P 500 | 60.4% | 30.0% |
| Active share vs the S&P 500 | 99.0% | 99.0% |
| In the Nasdaq-100 | 47.2% | 19.5% |
| Holdings | 24 | 33 |
| Top ten, share of the fund | 72.4% | 46.7% |
| Expense ratio | 0.35% | 0.59% |
| Fee for the differing part | 0.35% | 0.60% |
| Total return, 1 year | +40.5% | +36.2% |
| vs the S&P 500 | +23.9 pts | +19.6 pts |
| vs the Nasdaq-100 | +18.7 pts | +14.4 pts |
| Below its high | −4.0% | −3.9% |
| Net assets | $470m | $414m |
BBH in plain words
By weight, 60% of BBH's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 99%. The top ten holdings are 72% of the fund across 24 positions, as published by its issuer for Sep 18, 2026. Over the year to Sep 18, 2026 the fund returned +40.5% with distributions reinvested against +16.6% for the S&P 500, so a holder was ahead by 23.9 pts.
PBE in plain words
By weight, 30% of PBE's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 99%. The top ten holdings are 47% of the fund across 33 positions, as published by its issuer for Sep 19, 2026. Over the year to Sep 18, 2026 the fund returned +36.2% with distributions reinvested against +16.6% for the S&P 500, so a holder was ahead by 19.6 pts.
Questions people ask
- Do BBH and PBE hold the same stocks?
- By their latest filings, 44% of their books are the same securities at the same weight, which is a meaningful overlap. Overlap is the sum of the smaller weight of every security they share.
- Which is more different from the S&P 500, BBH or PBE?
- BBH has 60% of its weight in S&P 500 names and PBE has 30%, so BBH differs more from the index.
- Which is cheaper, BBH or PBE?
- BBH charges 0.35% a year and PBE charges 0.59%, so BBH is cheaper. Fees come from each fund's prospectus.
Other comparisons
Where these figures came from
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.
Cite this page. ETFIQ, BBH against PBE, data as of Sep 18, 2026. https://etfiq.com/compare/themes/bbh-vs-pbe Free to use with attribution; the underlying files are at Open data.